Last reviewed · How we verify
P. falciparum IBSM infection — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
P. falciparum IBSM infection (P. falciparum IBSM infection) — Medicines for Malaria Venture.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| P. falciparum IBSM infection TARGET | P. falciparum IBSM infection | Medicines for Malaria Venture | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- P. falciparum IBSM infection CI watch — RSS
- P. falciparum IBSM infection CI watch — Atom
- P. falciparum IBSM infection CI watch — JSON
- P. falciparum IBSM infection alone — RSS
Cite this brief
Drug Landscape (2026). P. falciparum IBSM infection — Competitive Intelligence Brief. https://druglandscape.com/ci/p-falciparum-ibsm-infection. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab